Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    Open Studies | "Drug Hypersensitivity"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Drug Hypersensitivity"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Management of Drug Hypersensitivity in Children
Condition: Drug Hypersensitivity
Intervention:
2 Unknown  Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
3 Recruiting Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Condition: Drug Allergy
Intervention: Drug: Omalizumab
4 Not yet recruiting Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Conditions: Adverse Drug Reaction;   Drug Allergy
Intervention:
5 Recruiting Quality of Life of Patients With a History of Drug Allergy in Thailand
Condition: Quality of Life
Intervention: Other: Questionnaires
6 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
7 Recruiting The Diagnosis of Penicillin/Aminopenicillin Allergy in Thailand
Conditions: Penicillin Allergy;   Aminopenicillin Allergy
Intervention:
8 Unknown  Prevention of Capecitabine Induced Hand and Foot Syndrome
Condition: Cancer
Intervention: Device: socks containing copper-oxide fibers
9 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
10 Unknown  A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy
Condition: Hand and Foot Syndrome
Interventions: Drug: vitamin b6;   Drug: placebo
11 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
12 Unknown  Ciclosporin in the Management of New Erythema Nodosum Leprosum
Condition: Leprosy
Interventions: Drug: Ciclosporin;   Drug: prednisolone
13 Not yet recruiting Testing the Effectiveness of Henna on Managing PPE
Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna;   Drug: Placebo
14 Not yet recruiting Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Conditions: Colon Adenocarcinoma;   Fatigue;   Palmar-Plantar Erythodysthesia;   Rectal Adenocarcinoma;   Recurrent Colon Carcinoma;   Recurrent Rectal Carcinoma;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Drug: Regorafenib;   Drug: Clobetasol Propionate;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment
15 Unknown  Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
Conditions: Palmar-Plantar Erythrodysesthesia;   Breast Cancer
Interventions: Drug: Ointment;   Drug: 0.1% Uracil Ointment
16 Unknown  Montelukast in ENL Reaction
Conditions: Erythema Nodosum Leprosum;   Leprosy
Intervention: Drug: montelukast in treatment of ENL reaction
17 Recruiting MARY D&Apos;UOL REPAIR BALM IN THE PREVENTION OF SKIN TOXICITY BY CAPECITABINE
Condition: Dermatitis, Adverse Drug Reaction
Interventions: Procedure: BALM ARM;   Procedure: PLACEBO ARM
18 Unknown  Challenge Test for Acetylsalicylic Acid Hypersensitivity
Conditions: Asthma Aspirin-sensitive;   ASA Intolerant Asthma;   Asthma, Aspirin-Induced;   Asthma, Nasal Polyps, and Aspirin Intolerance
Interventions: Drug: Acetylsalicylate;   Drug: Isotonic NaCl
19 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
20 Recruiting High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Conditions: ASA Triad;   Asthma, Nasal Polyps, And Aspirin Intolerance
Intervention: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years